Search results for " DIAGNOSIS"

showing 10 items of 1378 documents

Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables

2014

This retrospective study investigated, in two cohorts of subjects living in Southern Italy and awaiting treatment for oral squamous cell carcinoma (OSCC), the variables related to diagnostic delay ascribable to the patient, with particular reference to the cognitive and psychological ones. A total of 156 patients with OSCC (mean age: 62 years, M/F: 2.39∶1) were recruited at the Universities of Palermo and Naples. Risk factors related to patient delay included: sociodemographic, health-related, cognitive and psychological variables. The analysis was conducted by considering two different delay ranges: dichotomous (≤1 month vs. >1 month) and polytomous (3 months) delay. Data were investigated…

AdultMaleHealth Knowledge Attitudes Practicemedicine.medical_specialtyPathologyDelayed DiagnosisMultivariate analysisdiagnosisHealth BehaviorPopulationDenial PsychologicalCohort StudiesCognitionSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineHumanseducationGeneral DentistryAgedRetrospective StudiesAged 80 and overMouth neoplasmeducation.field_of_studybusiness.industryAge FactorsPolytomous Rasch modelRetrospective cohort studyFearOdds ratioAwarenessMiddle AgedConfidence intervaldiagnosiSocioeconomic FactorsOral squamous cell carcinomaCarcinoma Squamous CellOriginal ArticleFemaleMouth Neoplasmscognitive/psychological factorsbusinessAttitude to Healthpatient delayCohort studyInternational Journal of Oral Science
researchProduct

Editor's Note: Relates to: ‘Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to p…

2020

Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD). Methods and results Of the theoretical estimated prevalence of 1/500 for heterozygous FH, <1% are diagnosed in most countries. Recently, direct screening in a Northern European general population diagnosed approximately 1/200 with heterozygous FH. All reported studies document failure to achieve recommended LDL cholesterol targets in a large proportion of individuals with FH, and up to 13-fold increased risk of CHD. Based on prevalen…

AdultMaleHeterozygoteConsensusCost-Benefit AnalysisCoronary DiseaseRisk AssessmentHyperlipoproteinemia Type IIHumansAcademicSubjects/MED00200ChildAnticholesteremic AgentsLow-density lipoproteinHomozygoteCholesterol LDLMiddle AgedCardiovascular diseaseAtherosclerosisCorrigendaPedigreeCoronary heart diseaseCholesterolEarly DiagnosisTreatment OutcomeCurrent OpinionChild PreschoolMutationFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsDelivery of Health CareForecastingEuropean Heart Journal
researchProduct

Mutation screening for the prothrombin variant G20210A by melting point analysis with the Light Cycler system: atypical results, detection of the var…

2005

In the differential diagnosis of thrombophilic disorders genotyping of prothrombin and factor V are nowadays performed as a routine analysis. In the following we describe the unusual results of the mutation screening using melting point analysis for two patients and the consecutive detection of the mutation C20209T by sequencing the corresponding gene fragments. The molecular result is discussed with special respect to the medical history, ethnic background and clinical findings of both patients.

AdultMaleHot TemperatureDNA Mutational AnalysisClinical BiochemistryBiologyNucleic Acid DenaturationThrombophiliaPolymerase Chain Reactionlaw.inventionlawmedicineHumansPoint MutationThrombophiliaMedical historyGenotypingPolymerase chain reactionGeneticsPoint mutationBiochemistry (medical)Factor VSequence Analysis DNAHematologyGeneral Medicinemedicine.diseaseMutation (genetic algorithm)biology.proteinFemaleProthrombinDifferential diagnosisClinical and Laboratory Haematology
researchProduct

FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome

2005

Preimplantation genetic diagnosis (PGD) has transformed the approach to the infertility patient in the IVF setting. Although the principal applications of PGD have been to prevent the transmission of sex-linked diseases, in time and with growing knowledge of the chromosomal abnormalities observed in preimplantation embryos, its applications have widened. Nowadays, apart from its implications in the prevention of transmission of chromosomal and genetic abnormalities, PGD is being used with increased frequency to improve the IVF outcome in patients with advanced maternal age (or =38 years of age), recurrent miscarriage (or =2 miscarriages), recurrent IVF failure (or =3 failed IVF attempts) an…

AdultMaleInfertilityAbortion Habitualmedicine.medical_specialtyTime FactorsBiopsyAneuploidyFertilization in VitroBiologyAbortionPreimplantation genetic diagnosisChromosomesMale infertilityPregnancyRecurrent miscarriagemedicineHumansAdvanced maternal ageIn Situ Hybridization FluorescenceInfertility MaleChromosome AberrationsGynecologyPregnancyObstetricsPregnancy OutcomeObstetrics and GynecologyMiddle AgedAneuploidyEmbryo Mammalianmedicine.diseaseBlastocystTreatment OutcomeReproductive MedicineInfertilityFemaleInfertility FemaleMaternal AgeDevelopmental BiologyReproductive BioMedicine Online
researchProduct

Glut-1 Expression and In Situ CD1a/CD57 Immunologic Deficit in Keratoacanthoma and Squamous Cell Carcinoma of Immunocompetent Patients

2011

It is not easy to reach a differential diagnosis between keratoacanthoma (KA) and squamous cell carcinoma (SCC) and furthermore there is still considerable discussion about the relationship of these 2 tumors with immunity. To facilitate such a diagnosis, we assessed the Glut-1 antibody, reported to be strongly and diffusely expressed in SCC but never assessed in KA. We studied 43 lesions of immunocompetent patients: 17 SCCs, 13 typical KAs (tKAs), and 13 atypical KAs (aKAs), with histologic features of SCC in less than 30% of the lesions. In tKA, Glut-1 stained only the basal layers of the squamous nests (basal pattern) whereas in SCC the squamous nests were randomly and diffusely stained (…

AdultMaleKeratoacanthomaPathologymedicine.medical_specialtySkin NeoplasmsHistologySettore MED/08 - Anatomia PatologicaSkin DiseasesPathology and Forensic MedicineAntigens CD1Diagnosis DifferentialBasal (phylogenetics)CD57 AntigensAntigenBiomarkers TumorCarcinomamedicineHumansAgedAged 80 and overCD20biologybusiness.industryGlut-1 Keratoacanthoma Squamous cell carcinoma CD1aImmunityMiddle Agedmedicine.diseaseKeratoacanthomastomatognathic diseasesMedical Laboratory TechnologyExcitatory Amino Acid Transporter 2Carcinoma Squamous CellDisease Progressionbiology.proteinFemaleDifferential diagnosisSkin cancerbusinessCD8Applied Immunohistochemistry &amp; Molecular Morphology
researchProduct

Synovial sarcoma and malignant mesothelioma of the pleura: Review, differential diagnosis and possible role of apoptosis

2001

Synovial sarcoma of the pleural cavity is exceptionally rare and may be confused, both clinically and histologically, with malignant mesothelioma, with subsequent inappropriate therapy. To address this dilemma, four biphasic synovial sarcomas (BSSs) and four biphasic malignant mesotheliomas (BMMs) were studied with a panel of mucin and immunohistochemical stains to determine if they would allow one to distinguish between the two. The BMMs were all pleural-based. The BSSs were extrapleural. The mucin and immunohistochemical stains were all performed on formalin-fixed, paraffin-embedded tissue using standard techniques, with appropriate positive and negative controls. Mucin present in BSS is,…

AdultMaleMesotheliomaPathologymedicine.medical_specialtyAdolescentPleural Neoplasms2734ApoptosisPathology and Forensic MedicineNeoplasms Multiple PrimarySynovial sarcomaSarcoma SynovialPleural diseaseBiomarkers TumormedicineHumansMesotheliomaMalignant mesotheliomaAgedAged 80 and overStaining and Labelingbusiness.industryMucinApoptosis; Immunohistochemistry; Malignant mesothelioma; Synovial sarcoma; 2734MucinsApoptosiMiddle AgedPeriodic Acid-Schiff ReactionPleural cavitymedicine.diseaseImmunohistochemistrySynovial sarcomamedicine.anatomical_structureFemaleAlcian BlueSarcomaNeoplasm Recurrence LocalDifferential diagnosisCalretininbusiness
researchProduct

Prospective assessment of postoperative pain after craniotomy.

2010

Pain after craniotomy may be underdiagnosed, despite the fact that it can increase postoperative complications for example arterial hypertension and postoperative hemorrhage. This study investigates the incidence and intensity of pain after craniotomy and characterizes the influencing parameters. During a 1-year period 256 patients undergoing elective craniotomy were prospectively included in the study. Intensity of pain was evaluated 1, 4, and 24 hours after extubation using a verbal numerical rating scale (NRS) ranging from 0 (no pain) to 10 (maximal pain). Routine perioperative pain management was not influenced by the investigators. Parameters including patient-related factors, drug adm…

AdultMaleMethyl EthersPirinitramideAgingAdolescentCritical Caremedicine.medical_treatmentPostoperative painAnesthesia GeneralNeurosurgical ProceduresSevofluraneYoung AdultmedicineHumansProspective StudiesYoung adultProspective cohort studyCraniotomyAgedPain MeasurementAged 80 and overPain Postoperativebusiness.industryIncidence (epidemiology)BrainMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicinePostoperative diagnosisLogistic ModelsAnesthesiaAnesthetics InhalationAnesthesia IntravenousSurgeryFemaleNeurology (clinical)businessAnesthesia InhalationCraniotomyJournal of neurosurgical anesthesiology
researchProduct

Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1

2001

ABSTRACT A group of 76 consecutive human immunodeficiency virus (HIV)-positive patients with fever of unknown origin ( n = 52) or fever associated with pulmonary diseases was evaluated in order to assess the usefulness of PCR with peripheral blood in the diagnosis and follow-up of visceral leishmaniasis. We identified 10 cases of visceral leishmaniasis among the 52 patients with fever of unknown origin. At the time of diagnosis, all were parasitemic by PCR with peripheral blood. During follow-up, a progressive decline in parasitemia was observed under therapy, and all patients became PCR negative after a median of 5 weeks (range, 6 to 21 weeks). However, in eight of nine patients monitored …

AdultMaleMicrobiology (medical)Settore MED/17 - Malattie InfettiveLeishmania donovaniHIV InfectionsParasitemiaPolymerase Chain ReactionImmunopathologymedicineAnimalsHumansLeishmania infantumFever of unknown originbiologyLeishmaniasisDNA ProtozoanMiddle AgedPrognosisvisceral leishmaniasis; HIV; PCR diagnosisSettore MED/07 - Microbiologia e Microbiologia Clinicabiology.organism_classificationmedicine.diseaseVisceral leishmaniasisImmunologyHIV-1Leishmaniasis VisceralFemaleParasitologyViral diseaseLeishmania infantumPolymorphism Restriction Fragment LengthLeishmania donovaniJournal of Clinical Microbiology
researchProduct

Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients

2004

The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipients. Among 29 centers, MBI was diagnosed in 0.79% of 1513 allogeneic and 0.23% of 3012 autologous SCT recipients during 1994-1998 a median of 160 days after transplantation. The mean interval between first symptoms and diagnosis was 29 days and was still longer for patients with atypical MBI or recipients of corticosteroid therapy. The prevalence of MBI was highest among those who received matched unrelated or mismatched STCs from related donors. …

AdultMaleMicrobiology (medical)medicine.medical_specialtyTuberculosisAdolescentmedicine.drug_classmedicine.medical_treatmentHematopoietic stem cell transplantationOpportunistic InfectionsInternal medicineEpidemiologymedicineHumansTuberculosisChildRetrospective StudiesMycobacterium Infectionsbusiness.industryIncidenceHematopoietic Stem Cell TransplantationMiddle Agedmedicine.diseaseSurgeryTransplantationsurgical procedures operativeInfectious Diseasesmedicine.anatomical_structureLate diagnosisChild PreschoolCorticosteroidFemaleBone marrowStem cellbusinessStem Cell TransplantationClinical Infectious Diseases
researchProduct

Deciphering exome sequencing data: Bringing mitochondrial DNA variants to light

2019

The expanding use of exome sequencing (ES) in diagnosis generates a huge amount of data, including untargeted mitochondrial DNA (mtDNA) sequences. We developed a strategy to deeply study ES data, focusing on the mtDNA genome on a large unspecific cohort to increase diagnostic yield. A targeted bioinformatics pipeline assembled mitochondrial genome from ES data to detect pathogenic mtDNA variants in parallel with the "in-house" nuclear exome pipeline. mtDNA data coming from off-target sequences (indirect sequencing) were extracted from the BAM files in 928 individuals with developmental and/or neurological anomalies. The mtDNA variants were filtered out based on database information, cohort …

AdultMaleMitochondrial DNAAtaxiaAdolescentDevelopmental Disabilities[SDV]Life Sciences [q-bio]BiologyDNA MitochondrialGenomeHaplogroupYoung Adult03 medical and health sciencesExome SequencingGeneticsmedicineHumansChildExomeGenetics (clinical)Exome sequencingComputingMilieux_MISCELLANEOUSAged030304 developmental biologyAged 80 and overGenetics0303 health sciences030305 genetics & heredityInfant NewbornComputational BiologyGenetic VariationInfantMiddle AgedPhenotypeEarly DiagnosisChild PreschoolFemaleNervous System Diseasesmedicine.symptom
researchProduct